These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 25183855)

  • 1. The Candida pathogenic species complex.
    Turner SA; Butler G
    Cold Spring Harb Perspect Med; 2014 Sep; 4(9):a019778. PubMed ID: 25183855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.
    Sadeghi G; Ebrahimi-Rad M; Mousavi SF; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
    J Mycol Med; 2018 Mar; 28(1):51-58. PubMed ID: 29366545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
    Krcmery V; Barnes AJ
    J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance.
    Silva S; Negri M; Henriques M; Oliveira R; Williams DW; Azeredo J
    FEMS Microbiol Rev; 2012 Mar; 36(2):288-305. PubMed ID: 21569057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida glabrata among Candida spp. from environmental health practitioners of a Brazilian Hospital.
    Savastano C; de Oliveira Silva E; Gonçalves LL; Nery JM; Silva NC; Dias AL
    Braz J Microbiol; 2016; 47(2):367-72. PubMed ID: 26991302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and Antifungal Susceptibility of
    Badiee P; Boekhout T; Haddadi P; Mohammadi R; Ghadimi-Moghadam A; Soltani J; Zarei Mahmoudabadi A; Ayatollahi Mousavi SA; Najafzadeh MJ; Diba K; Salimi-Khorashad AR; Amin Shahidi M; Ghasemi F; Jafarian H
    Microbiol Spectr; 2022 Dec; 10(6):e0245322. PubMed ID: 36445122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001].
    Mujica MT; Finquelievich JL; Jewtuchowicz V; Iovannitti CA
    Rev Argent Microbiol; 2004; 36(3):107-12. PubMed ID: 15559191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of molecular epidemiology of candidiasis in portugal by PCR fingerprinting of Candida clinical isolates.
    Correia A; Sampaio P; Almeida J; Pais C
    J Clin Microbiol; 2004 Dec; 42(12):5899-903. PubMed ID: 15583336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Caspofungin use in patients with invasive candidiasis caused by common non-albicans Candida species: review of the caspofungin database.
    Colombo AL; Ngai AL; Bourque M; Bradshaw SK; Strohmaier KM; Taylor AF; Lupinacci RJ; Kartsonis NA
    Antimicrob Agents Chemother; 2010 May; 54(5):1864-71. PubMed ID: 20231388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90.
    Matthews RC; Rigg G; Hodgetts S; Carter T; Chapman C; Gregory C; Illidge C; Burnie J
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2208-16. PubMed ID: 12821470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of Both Pathogenic and Nonpathogenic CUG Clade
    Pountain AW; Collette JR; Farrell WM; Lorenz MC
    mBio; 2021 Dec; 12(6):e0331721. PubMed ID: 34903044
    [No Abstract]   [Full Text] [Related]  

  • 14. Candida isolates causing candidemia show different degrees of virulence in Galleria mellonella.
    Marcos-Zambrano LJ; Bordallo-Cardona MÁ; Borghi E; Falleni M; Tosi D; Muñoz P; Escribano P; Guinea J
    Med Mycol; 2020 Jan; 58(1):83-92. PubMed ID: 30874807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 to 1998) multicenter surveillance study in Quebec, Canada.
    St-Germain G; Laverdière M; Pelletier R; Bourgault AM; Libman M; Lemieux C; Noël G
    J Clin Microbiol; 2001 Mar; 39(3):949-53. PubMed ID: 11230409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group.
    Pfaller MA; Jones RN; Doern GV; Sader HS; Hollis RJ; Messer SA
    J Clin Microbiol; 1998 Jul; 36(7):1886-9. PubMed ID: 9650930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A yeast by any other name: Candida glabrata and its interaction with the host.
    Kaur R; Domergue R; Zupancic ML; Cormack BP
    Curr Opin Microbiol; 2005 Aug; 8(4):378-84. PubMed ID: 15996895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative virulence of Candida auris with Candida haemulonii, Candida glabrata and Candida albicans in a murine model.
    Fakhim H; Vaezi A; Dannaoui E; Chowdhary A; Nasiry D; Faeli L; Meis JF; Badali H
    Mycoses; 2018 Jun; 61(6):377-382. PubMed ID: 29460345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
    Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
    Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution and antifungal susceptibility pattern of
    Bilal H; Shafiq M; Hou B; Islam R; Khan MN; Khan RU; Zeng Y
    Virulence; 2022 Dec; 13(1):1573-1589. PubMed ID: 36120738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.